Stay updated on Nivolumab vs Cabiralizumab in T Cell Lymphoma Clinical Trial

Sign up to get notified when there's something new on the Nivolumab vs Cabiralizumab in T Cell Lymphoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab vs Cabiralizumab in T Cell Lymphoma Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    Revision label updated from v3.6.5 to v3.6.6. This indicates a small maintenance update to the site's versioning rather than a change to content or user-visible features.
    Difference
    0.1%
    Check dated 2026-09-01T18:20:37.000Z thumbnail image
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    No Change Detected
  4. Check
    27 days ago
    Change Detected
    Summary
    The page revision indicator changed from v3.6.4 to v3.6.5, indicating a new version of the page. This change does not affect study details or visible content.
    Difference
    0.1%
    Check dated 2026-08-11T08:29:55.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    Revision: v3.6.4 replaces v3.6.3 as the site revision indicator, reflecting a small update to the page. This change does not affect study data or how the page functions.
    Difference
    0.1%
    Check dated 2026-07-28T04:50:19.000Z thumbnail image
  6. Check
    63 days ago
    Change Detected
    Summary
    The page's revision was updated from v3.6.2 to v3.6.3, indicating an administrative update to the study record. This reflects an administrative change rather than updates to the study data.
    Difference
    0.1%
    Check dated 2026-07-06T15:49:14.000Z thumbnail image
  7. Check
    70 days ago
    Change Detected
    Summary
    The page revision was updated from v3.6.0 to v3.6.2, indicating a minor maintenance update to the study page. There is no change to substantive study information such as eligibility criteria, endpoints, or locations.
    Difference
    0.1%
    Check dated 2026-06-29T08:46:16.000Z thumbnail image
  8. Check
    85 days ago
    Change Detected
    Summary
    Recruitment status updated to indicate enrollment is closed, reflecting a completed study. Additional changes introduce new help/navigation sections (How to Read a Study Record, Common Questions, How to Join a Study) and a revision label update, signaling UI/content organization updates.
    Difference
    0.4%
    Check dated 2026-06-14T20:37:55.000Z thumbnail image

Stay in the know with updates to Nivolumab vs Cabiralizumab in T Cell Lymphoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab vs Cabiralizumab in T Cell Lymphoma Clinical Trial page.